|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2022―Jun―25 |
Natural and genetically-modified animal models to investigate pulmonary and extrapulmonary manifestations of COVID-19 |
Shikha Tiwari, Garima Goel, Ashok Kumar |
2 |
[GO] |
2022―May―28 |
SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies |
Wenping Gong, Seppo Parkkila, Xueqiong Wu, Ashok Aspatwar |
3 |
[GO] |
2021―Dec―28 |
An update on host immunity correlates and prospects of re-infection in COVID-19 |
Neema Negi, Shesh Prakash Maurya, Ravinder Singh, Bimal Kumar Das |
4 |
[GO] |
2021―Sep―16 |
COVID-19 and oral diseases: Assessing manifestations of a new pathogen in oral infections |
Afsar R. Naqvi, Joel Schwartz, Daniela Atili Brandini, Samantha Schaller, Heba Hussein, Araceli Valverde, et al. (+2) Raza Ali Naqvi, Deepak Shukla |
5 |
[GO] |
2021―Sep―08 |
Antibody Response against SARS-CoV-2 Infection: Implications for Diagnosis, Treatment and Vaccine Development |
Alessandra Mallano, Alessandro Ascione, Michela Flego |
6 |
[GO] |
2021―Aug―11 |
Insights into the modulation of the interferon response and NAD+ in the context of COVID-19 |
Nada J. Habeichi, Cynthia Tannous, Andriy Yabluchanskiy, Raffaele Altara, Mathias Mericskay, George W. Booz, Fouad A. Zouein |
7 |
[GO] |
2021―Jul―12 |
Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia |
Natalija Novak, Leticia Tordesillas, Beatriz Cabanillas |
8 |
[GO] |
2021―May―12 |
Tapping the immunological imprints to design chimeric SARS-CoV-2 vaccine for elderly population |
Asim Biswas, Rahul Subhra Mandal, Suparna Chakraborty, George Maiti |
9 |
[GO] |
2021―May―08 |
Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic |
Ashok Aspatwar, Wenping Gong, Shuyong Wang, Xueqiong Wu, Seppo Parkkila |
10 |
[GO] |
2021―Apr―05 |
COVert IDentities of current worldwide pandemic |
Kumar Akhilesh, Das Nilanjana, Kumar Himanshu |
11 |
[GO] |
2021―Feb―27 |
COVID-19: Immunology, Immunopathogenesis and Potential Therapies |
Asha Bhardwaj, Leena Sapra, Chaman Saini, Zaffar Azam, Pradyumna K. Mishra, Bhupendra Verma, et al. (+2) Gyan C. Mishra, Rupesh K. Srivastava |
12 |
[GO] |
2021―Feb―22 |
Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality |
Yifan Que, Chao Hu, Kun Wan, Peng Hu, Runsheng Wang, Jiang Luo, et al. (+9) Tianzhi Li, Rongyu Ping, Qinyong Hu, Yu Sun, Xudong Wu, Lei Tu, Yingzhen Du, Christopher Chang, Guogang Xu |
13 |
[GO] |
2021―Jan―15 |
Molecular Diagnostic Tools for the Detection of SARS-CoV-2 |
Manali Datta, Desh Deepak Singh, Afsar R. Naqvi |
14 |
[GO] |
2021―Jan―15 |
Rapid diagnosis of SARS-CoV-2 using potential point-of-care electrochemical immunosensor: Toward the future prospects |
Pushpesh Ranjan, Ayushi Singhal, Shalu Yadav, Neeraj Kumar, S. Murali, Sunil K Sanghi, Raju Khan |
15 |
[GO] |
2020―Nov―16 |
Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome |
Rodrigo Cerqueira Borges, Miriam Sayuri Hohmann, Sergio Marques Borghi |
16 |
[GO] |
2020―Nov―06 |
How could we forget immunometabolism in SARS-CoV2 infection or COVID-19? |
Vijay Kumar |
17 |
[GO] |
2020―Oct―28 |
Pathogenesis guided therapeutic management of COVID-19: an immunological perspective |
Ashutosh Kumar, Pranav Prasoon, Prakash S. Sekhawat, Vikas Pareek, Muneeb A. Faiq, Chiman Kumari, et al. (+3) Ravi K. Narayan, Maheswari Kulandhasamy, Kamla Kant |
18 |
[GO] |
2020―Aug―03 |
Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us |
Vijay Kumar |
19 |
[GO] |
2020―Apr―29 |
Can melatonin reduce the severity of COVID-19 pandemic? |
Alex Shneider, Aleksandr Kudriavtsev, Anna Vakhrusheva |